Clinical significance of CA125 level after the first cycle of chemotherapy on survival of patients with advanced ovarian cancer

Purpose To determine the most powerful cancer antigen 125 (CA125)-related prognostic factor for advanced epithelial ovarian cancer (EOC) and to identify cut-off values that distinguish patients with a poor prognosis from those with a good prognosis.